Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Study finds pain gene affects success of chronic pain medicine in women

Study finds pain gene affects success of chronic pain medicine in women
p p Read More

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide

July 19, 2024 chronic pelvic pain, gabapentin, Neuregulin 3, News, Pfizer, University of Edinburgh, university of oxford

Glasgow scientists develop first bone marrow model to support human stem cells

Glasgow scientists develop first bone marrow model to support human stem cells
p p Read More

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia

July 19, 2024 blood cancer, bone marrow model, leukaemia, long-term haematopoietic stem cells, News, University of Glasgow

Sounds great – HCA milestone for PharmaTimes Communications Awards

Sounds great – HCA milestone for PharmaTimes Communications Awards
p p Read More

Accreditation recognises ‘continued professional development’ opportunities

July 19, 2024 communicationawards, HCA, News, PharmaTimes

Study reveals new AI tool predicts recurrence of prostate cancer by a decade

Study reveals new AI tool predicts recurrence of prostate cancer by a decade
p p Read More

The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths

July 18, 2024 artificial intelligence, Institute of Cancer Research, News, Oncology, prostate cancer, Royal Marsden NHS Foundation Trust

Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia

Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia
p p Read More

Genentech’s Pulmozyme could also treat other respiratory infections and conditions

July 18, 2024 dornase alfa, Francis Crick Institute, Genentech, LifeArc, News, Pulmozyme, UCL Hospital, University College London

McMaster researchers develop way to make phages more accessible

McMaster researchers develop way to make phages more accessible
p p Read More

The new technology can generate a target infection within 30 minutes to two hours

July 17, 2024 antibiotic-resistant infections, bacteriophages, McMaster University, News, phages, Université Laval

US study reveals Co-STAR receptor cells show promise in treating cancers

US study reveals Co-STAR receptor cells show promise in treating cancers
p p Read More

The most globally prevalent cancers include breast, lung, bowel and prostate cancers

July 17, 2024 Bloomberg-Kimmel Institute for Cancer Immunotherapy, Cancer, co-stimulatory synthetic T-cell receptor and antigen receptor, John Hopkins Ludwig Center, Johns Hopkins Kimmel Center, Lustgarten Laboratory, News, Oncology

KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer

KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer
p p Read More

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK

July 16, 2024 blood cancer, immune profiling, immune response, King’s College London, myelodysplastic syndromes, News

Study finds Parkinson’s disease SLT more effective than one used in NHS

Study finds Parkinson’s disease SLT more effective than one used in NHS
p p Read More

The progressive neurodegenerative condition affects around 153,000 people in the UK

July 16, 2024 Lee Silverman Voice Treatment, neurodegenerative conditions, News, Parkinson's disease, PD-COMM, speech and language therapy, University of Birmingham, University of Nottingham

Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use

Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use
p p Read More

Affecting parts of the body involving breathing, RTIs impact one in five people in England

July 15, 2024 antibiotics, nasal sprays, News, respiratory tract infections, University of Bristol, University of Southampton

Posts navigation

Posts pagination

« Previous 1 … 30 31 32 … 59 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy